383 related articles for article (PubMed ID: 28591133)
41. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
[TBL] [Abstract][Full Text] [Related]
42. Red clover for treatment of hot flashes and menopausal symptoms: A systematic review and meta-analysis.
Ghazanfarpour M; Sadeghi R; Roudsari RL; Khorsand I; Khadivzadeh T; Muoio B
J Obstet Gynaecol; 2016; 36(3):301-11. PubMed ID: 26471215
[TBL] [Abstract][Full Text] [Related]
43. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
Deecher DC; Dorries K
Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
[TBL] [Abstract][Full Text] [Related]
44. Isoflavone treatment for acute menopausal symptoms.
Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
[TBL] [Abstract][Full Text] [Related]
45. Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial.
Pinkerton JV; Archer DF; Guico-Pabia CJ; Hwang E; Cheng RF
Menopause; 2013 Jan; 20(1):38-46. PubMed ID: 23266839
[TBL] [Abstract][Full Text] [Related]
46. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: a randomized, double-blind, placebo-controlled study.
Hirose A; Terauchi M; Akiyoshi M; Owa Y; Kato K; Kubota T
Arch Gynecol Obstet; 2016 Mar; 293(3):609-15. PubMed ID: 26294070
[TBL] [Abstract][Full Text] [Related]
47. Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound.
Prior JC; Hitchcock CL
Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():7-11. PubMed ID: 22849758
[TBL] [Abstract][Full Text] [Related]
48. Effects of soy isoflavones on menopausal neurovegetative symptoms.
Colacurci N; Zarcone R; Borrelli A; De Franciscis P; Fortunato N; Cirillo M; Fornaro F
Minerva Ginecol; 2004 Oct; 56(5):407-12. PubMed ID: 15531858
[TBL] [Abstract][Full Text] [Related]
49. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
Prague JK; Roberts RE; Comninos AN; Clarke S; Jayasena CN; Nash Z; Doyle C; Papadopoulou DA; Bloom SR; Mohideen P; Panay N; Hunter MS; Veldhuis JD; Webber LC; Huson L; Dhillo WS
Lancet; 2017 May; 389(10081):1809-1820. PubMed ID: 28385352
[TBL] [Abstract][Full Text] [Related]
50. Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial.
Pan Y; Meister R; Löwe B; Winkelmann A; Kaptchuk TJ; Buhling KJ; Nestoriuc Y
Trials; 2019 Aug; 20(1):508. PubMed ID: 31420050
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review.
Chen MN; Lin CC; Liu CF
Climacteric; 2015 Apr; 18(2):260-9. PubMed ID: 25263312
[TBL] [Abstract][Full Text] [Related]
52. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
Winther K; Rein E; Hedman C
Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
[TBL] [Abstract][Full Text] [Related]
53. S-equol: a potential nonhormonal agent for menopause-related symptom relief.
Utian WH; Jones M; Setchell KD
J Womens Health (Larchmt); 2015 Mar; 24(3):200-8. PubMed ID: 25692726
[TBL] [Abstract][Full Text] [Related]
54. [Effect of soy isoflavones on peri-menopausal symptom and estrogen].
Li Y; Liu K; Lei W; Zhang K
Wei Sheng Yan Jiu; 2010 Jan; 39(1):56-9. PubMed ID: 20364590
[TBL] [Abstract][Full Text] [Related]
55. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review.
Booth NL; Piersen CE; Banuvar S; Geller SE; Shulman LP; Farnsworth NR
Menopause; 2006; 13(2):251-64. PubMed ID: 16645539
[TBL] [Abstract][Full Text] [Related]
56. Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints.
Schmidt M; Arjomand-Wölkart K; Birkhäuser MH; Genazzani AR; Gruber DM; Huber J; Kölbl H; Kreft S; Leodolter S; Linsberger D; Metka M; Simoncini T; Vrabic Dezman L
Gynecol Endocrinol; 2016 Jun; 32(6):427-30. PubMed ID: 26943176
[TBL] [Abstract][Full Text] [Related]
57. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women.
Baber RJ; Templeman C; Morton T; Kelly GE; West L
Climacteric; 1999 Jun; 2(2):85-92. PubMed ID: 11910672
[TBL] [Abstract][Full Text] [Related]
58. A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency.
Jenks BH; Iwashita S; Nakagawa Y; Ragland K; Lee J; Carson WH; Ueno T; Uchiyama S
J Womens Health (Larchmt); 2012 Jun; 21(6):674-82. PubMed ID: 22409590
[TBL] [Abstract][Full Text] [Related]
59. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
Simon JA;
Menopause; 2006; 13(2):222-31. PubMed ID: 16645536
[TBL] [Abstract][Full Text] [Related]
60. A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages.
Fu SF; Zhao YQ; Ren M; Zhang JH; Wang YF; Han LF; Chang YX; Fan GW; Wang H; Huang YH; Zhai JB; Dong JY; Li X; Ai JQ; Zhang H; Zhu Y; Zhang BL; Sun LK; Fan X; Gao XM
Menopause; 2016 Mar; 23(3):311-23. PubMed ID: 26671188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
